Press Center: Articles

Practices
Industries
Jurisdictions

A plant variety as an asset: why up to 70% of royalties remain in the field

29 September 2026 "Pole Russia" magazine, September 29, 2026

Which terms of a license agreement help protect rights to a variety and control the reproduction of seeds

Seed traceability in Russia has made the illegal reproduction of varieties visible. But the right holder will receive money only within the limits fixed in the license agreement. Which mistakes in contracts leave breeders without royalties (license payments) and how to protect a variety for the entire term of its protection — in the author's column by Boris Malakhov, managing partner of the law firm Lidings.

"Lidings is About Life": Interview with Andrey Zelenin and Boris Malakhov

10 April 2026 Kommersant Newspaper, April 2026

A change of managing partner at a law firm is rarely just a personnel decision – more often, it is a test of the sustainability of the business model and the maturity of the partnership. Lidings partners Andrey Zelenin and his successor as managing partner, Boris Malakhov, argue that their transition was neither a crisis nor a reboot, but rather a confirmation of the viability of the chosen governance structure – one that maintains trust within the team and carefully adapts to a changing market.

The Pharmaceutical Industry in India: Patent Protection

01 April 2026 "Legal Insight" Magazine, April 2026

India has long and firmly established itself as the ‘pharmacy of the world’, as the country produces a fifth of all generics and provides affordable medicines to millions of people across the globe. However, India is now transitioning from copying innovative molecules to creating them. Amid the restructuring of global supply chains and strategic rapprochement with Russia, India is becoming both a battleground for fierce patent wars and a unique laboratory for joint research. How can Russian pharmaceutical companies establish intellectual property protection in a jurisdiction where the balance between the interests of pharmaceutical giants and the affordability of medicines for the population is enshrined in law? Boris Malakhov and Natalya Thotahewage analyse the key features of patenting and the prospects for technological alliances between Moscow and Delhi.